Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Smyrna, Georgia 30080


Purpose:

The purpose of the study is to investigate whether eight weeks of treatment with flexible doses of bifeprunox is superior to treatment with placebo in depressed patients with bipolar disorder.


Criteria:

Inclusion Criteria: - Diagnosis of bipolar disorder - Experiencing a depressive episode


NCT ID:

NCT00134459


Primary Contact:

Study Director
Medical Monitor, MD
Wyeth is now a wholly owned subsidiary of Pfizer


Backup Contact:

N/A


Location Contact:

Smyrna, Georgia 30080
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.